| SAR millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 254.1 | 240.0 | 156.4 | 236.4 | 245.4 | +3.8% | |
| Cost of revenue | 246.6 | 231.6 | 157.0 | 235.7 | 243.5 | +3.3% | |
| Gross profit | 7.6 | 8.3 | (0.6) | 0.7 | 1.9 | +179.0% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 3.9 | 6.6 | 3.6 | 7.3 | 2.5 | −65.3% | |
| Selling & marketing | 1.4 | 2.0 | 1.0 | 0.7 | 0.7 | −2.1% | |
| Operating expenses | 3.9 | 6.5 | 7.7 | 7.4 | 9.5 | +28.2% | |
| Operating income | 3.7 | 1.9 | (8.2) | (6.6) | (7.6) | −15.2% | |
| Interest expense | 0.2 | 0.9 | 1.3 | 2.1 | 1.5 | −27.6% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | 1.1 | (0.9) | (2.4) | 0.3 | (1.2) | −486.9% | |
| Pre-tax income | 4.8 | 1.0 | (10.6) | (6.0) | (8.8) | −47.5% | |
| Income tax | 0.6 | 0.2 | 1.0 | 1.6 | 1.4 | −17.8% | |
| Net income | 4.2 | 0.8 | (11.6) | (7.6) | (10.2) | −33.5% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | 0.43 | 0.09 | (0.95) | (0.66) | (0.83) | −25.8% | |
| EPS, diluted (per share) | 0.43 | 0.09 | (0.95) | (0.66) | (0.83) | −25.8% | |
| EBITDA | 8.9 | 6.3 | (4.2) | 1.1 | (2.8) | −356.8% | |
| Depreciation & amortization | 3.8 | 4.5 | 4.4 | 5.0 | 4.8 | −2.4% | |
| Weighted average shares (shares) | 9,750,000 | 9,750,000 | 12,187,506 | 11,606,507 | 12,251,000 | +5.6% | |
| Weighted average diluted shares (shares) | 9,750,000 | 9,750,000 | 12,187,500 | 11,606,507 | 12,251,000 | +5.6% | |
| Gross margin | 3.0% | 3.5% | −0.4% | 0.3% | 0.8% | +0.5 pts | |
| Operating margin | 1.4% | 0.8% | −5.3% | −2.8% | −3.1% | −0.3 pts | |
| Net margin | 1.7% | 0.3% | −7.4% | −3.2% | −4.1% | −0.9 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
